Ningaloo Biosystems GmbH

https://ningaloo.bio/news/

We are enthusiastic to share our preprint publication in collaboration with Prof. Dr. Dagmar Wachten from The University of Bonn and Prof. Dr. Andreas Möglich from University of Bayreuth of our latest research on an innovative optogenetic approach to enable titratable expression of biopharmaceuticals, including monoclonal and bispecific antibodies. The study was conducted with our innovative MLA-1 – a laboratory device that enables specific activation of optogenetic photoswitches in various well plate formats.   https://lnkd.in/e5k_UQyF   #InstituteOfInnateImmunity #UniversityOfBayreuth #Optogenetics #Biopharmaceuticals #CyberBiology #Research

📢 Dr. Elisa Ciglieri, scientist at Ningaloo Biosystems GmbH, presenting the MLA-1 (https://ningaloo.bio/mla-1), our latest development to open new chapters in #bioproduction and beyond. 📢 #synbio #optogenetics #deeptech #ningaloo

🚀 It’s a great feeling to see this technology coming to fruition and hitting the real world! Great job of the whole Ningaloo team and our partners to develop solutions enabling customers to use #nextlevelbiology.

🌟 Exciting News from Ningaloo Biosystems GmbH ! 🌟 We help you to take your work to the next level – by unlocking the new opportunities of cyber biotechnology! Discover our novel products and services at our booth at the 4th Optogenetic Technologies and Applications Conference – and see what’s next! #synbio #biotechnology #bioprocessing #optogenetics #DeepTech

🌍 Together, we can shape the future of biotechnology. ✨ At Ningaloo Biosystems, we are proud to be at the forefront of biopharmaceutical innovation! 🚀 By controlling cells in real-time, we enable the production of therapeutic proteins that are difficult to make. This not only paves the way to more efficient production but can also significantly improve manufacturing economics. How? Learn more at the upcoming 4th Optogenetic Technologies and Applications Conference in Boston, MA, starting on September 10, 2024. #biopharma #NextGenMedicines #optogenetics

🌟 Let’s open a new chapter in #bioproduction! 📖 Our mission is to transform the way biopharmaceuticals are manufactured through innovative technologies, thereby improving access to life-saving therapies. We firmly believe that cyber bioproduction can make a real difference - for scientists and patients worldwide. #biopharmaceuticals #synbio #cyberbiology

Meet us at the Future Tech Fest 2024! 🚀 Learn more about how #bioproduction of #AdvancedMedicines, such as #GeneTherapeutics, can be revolutionized - at Germany's largest B2B tech startup expo and conference organized by digihub - Digital Innovation Hub Düsseldorf/Rheinland GmbH.

At Ningaloo Bio we are thrilled about taking part in this year‘s BIO International Convention in San Diego - with a lot of focus on advanced biopharmaceutical modalities and the challenges to bring them from pre-clinical phase to the patients. Thanks to the BIO.NRW and NRW.Global Business teams for the great support at the German Pavilion!

Looking forward to meeting you at the BIO International Convention from June 3-6, 2024 in San Diego, CA to discuss #nextgeneration #bioproduction